Delhi High Court Orders Forensic Audit into Fortis Share Dissipation by Singh Brothers

In a significant move to enforce a long-pending international arbitral award, the Delhi High Court on Monday appointed a forensic auditor to investigate the systematic dissipation of Fortis Healthcare shares by former promoters Malvinder Mohan Singh and Shivinder Mohan Singh, allegedly in defiance of multiple court undertakings and status quo orders.

Justice Subramonium Prasad allowed applications by Japanese pharmaceutical major Daiichi Sankyo seeking a forensic examination of transactions involving Fortis Healthcare Ltd (FHL), its holding entity Fortis Healthcare Holding Pvt Ltd (FHHPL) controlled by the Singh brothers, banks, and Malaysia’s IHH Healthcare Berhad. The award, passed in 2016, directed the Singh brothers to pay ₹2,562 crore for concealing US regulatory probes during Daiichi's 2008 acquisition of Ranbaxy. With accrued interest, the amount now stands at approximately ₹5,300 crore.

"The difficulties of a litigant in India begin when he has obtained a Decree"

Opening his judgment with a quote from an 1872 Privy Council decision, Justice Prasad lamented that despite decades of such observations, “nothing has changed even today.” He noted that the award has remained unexecuted for nearly a decade while the judgment debtors enjoyed “several arrows up in his quiver to defeat the rights of a Decree Holder.”

The court recounted that from September 2016 to December 2018, FHHPL's unencumbered shareholding in FHL plunged from over 5.29 crore shares to a mere 6.01 lakh shares—a drop of nearly 99%—despite six solemn assurances given to the court by the Singh brothers that the asset base would be preserved. The Supreme Court had earlier convicted the brothers for contempt of court and directed the executing court to consider appointing a forensic auditor.

Assurances Broken, Assets Vanished

The Singh brothers personally controlled both FHHPL and FHL, serving as its Managing Director and Director until February 2018. Despite repeated undertakings—first in May 2016, then in January, March, and June 2017—that the unencumbered shares would be available to satisfy the decree, the holding was progressively pledged, transferred, and sold. The court found that these transactions occurred even after the Supreme Court passed status quo orders on August 11, 2017, and August 31, 2017, directing that the shareholding be maintained.

Fortis Healthcare contended that it was a separate legal entity and had no role in the transfers, arguing that shares of a listed company are freely transferable and that promoter entities were not required to obtain pre-clearance under insider trading regulations at the relevant time. The court rejected this defense, observing that the corporate veil must be pierced where the structure is used to defeat court orders.

“If FHL functioned as the alter ego or instrumentality of Judgment Debtors No. 1 and 6, its plea of complete ignorance cannot be accepted at face value without first undertaking a factual enquiry,” Justice Prasad held. The court noted that the entire share capital of FHHPL was beneficially held by the Singh brothers, granting them absolute control, and that FHL had knowledge of the proceedings through its own disclosures to stock exchanges.

Court's Power to Pierce the Corporate Veil

Relying on precedents including Renusagar Power Co. , ArcelorMittal India v. Satish Kumar Gupta , and Sita Ram v. Balbir , the court affirmed that the corporate veil may be lifted to prevent fraud or improper conduct. It also cited English authorities such as Seaward v. Paterson to hold that a third party who knowingly assists in violating an injunction is liable for contempt, even if not originally bound by the order.

“The Court cannot throw up its hands in despair and state that even if its Orders have been flouted, it cannot remedy the wrong other than by punishing the wrongdoers with imprisonment,” the judgment stated. The audit is intended to enable the court to “undo the wrongs committed” and restore the sanctity of judicial proceedings.

Scope of the Forensic Audit

The court appointed S Ramanand Aiyar & Co., Chartered Accountants, as the forensic auditor, directing it to complete the exercise within six months. The audit will cover:

  • The complete evolution of FHHPL’s shareholding in FHL from May 24, 2016 (date of first assurance) onward, including pledges, top-ups, transfers, and sales.
  • The role of FHL, its officers, directors, and compliance officer in processing or facilitating these transactions.
  • Transactions of 17 banks and financial institutions that extended loans secured by FHL shares, to determine whether only encumbered shares were dealt with or whether unencumbered shares were also converted.
  • The trail of consideration received from share sales and its destination.
  • The acquisition of a controlling stake in FHL by IHH Healthcare Berhad and the subsequent transfer of ₹4,666 crore to RHT Health Trust, Singapore.
  • All entities, downstream companies, and individuals involved in the decision-making at each stage.

All concerned parties—including banks, FHL, and downstream entities—must provide documents within two weeks of a requisition. Failure to comply will be treated as contempt.

Not a Finding of Liability

The court clarified that the forensic audit is “purely investigative in nature” and does not by itself fasten liability. The opinion of the auditor will be expert evidence enabling the executing court to determine appropriate relief, which may include restitution from those found to have aided the violations.

“The direction for forensic audit is not an exercise in futility. The forensic audit will pin point the exact manner by which this Court was deceived, the dramatis personae who aided and abetted in evasion of Court Orders by misleading the Court, so that the Court can take steps by fixing liability on the perpetrators of dissipation of shares to ensure that the majesty of law is upheld.”